EGFR and cancer: The Akt phosphorylation that is induced by EGFR signaling is attenuated in the absence of CNOT9 (Ajiro et al., 2010), which suggests that CNOT9 enhances EGFR signaling and contributes to carcinogenesis and progression of cancer, particularly in mammary glands.